AP Biosciences Inc (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 117.00
-9.50 (-7.51%)
Aug 12, 2025, 2:00 PM CST
Paramount Global Market Cap
AP Biosciences has a market cap or net worth of 10.77 billion as of August 11, 2025. Its market cap has increased by 191.69% in one year.
Market Cap
10.77B
Enterprise Value
9.30B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$117.00
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 10.77B, an increase of 111.29%. That is a compound annual growth rate of 43.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 10.77B | 154.95% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.18B |
| PharmaEssentia | 166.30B |
| Bora Pharmaceuticals Co., LTD. | 88.86B |
| Lotus Pharmaceutical | 56.28B |
| Oneness Biotech | 30.90B |
| Polaris Group | 27.31B |
| Center Laboratories | 26.39B |
| Pegavision | 24.38B |